Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting
-
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
-
Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)
-
PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annua
-
RCF Opportunities Fund II L.P. Files Early Warning Report Regarding Common Shares of Defense Metals Corp.
-
Abcourt Announces its Results for the Third Quarter Ended March 31, 2025
-
IMUNON Announces Withdrawal of Form S-1 Registration Statement
-
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
-
Daktronics to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28th
-
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025
-
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
-
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
-
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
-
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
-
ROHM Develops Compact Surface-Mount Near-Infrared LEDs Featuring Industry-Leading Radiant Intensity
-
Lynch Carpenter Investigates Claims in Marlboro-Chesterfield Pathology Data Breach
-
Lynch Carpenter Investigates Claims in Kettering Health Data Breach
-
Banco Comercial Português, S.A. informs about resolutions of the Annual General Meeting
-
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
-
Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
-
Petrus Announces Results of Annual General Meeting of Shareholders
-
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
-
Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
-
Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annu
-
Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Lyme Timber Receives the 2025 SFI Leadership in Conservation Award for Advancing Nature-Based Solutions in SFI-Certified Forests
-
Acceleware Ltd. Reports First Quarter 2025 Financial and Operating Results
-
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting
-
ImPact Biotech Announces Late-Breaking Podium Presentation at ASCO 2025 Highlighting ENLIGHTED Study Interim Analysis
-
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial Results in Earlier Lines of Treatment for Relapsed/Refractory Multiple Myeloma
-
Clear Blue Technologies International to provide Corporate Update and Report Q1 2025 Financial Results and Host Conference Call on Thursday, May 29th, 2025
-
THOR Industries Announces Date for its Fiscal 2025 Third Quarter Earnings Release
-
Bicara Therapeutics Announces Publication of an Abstract with Updated Interim Data from Phase 1/1b Trial of Ficerafusp alfa in 1L R/M HNSCC at the 2025 ASCO Annual Meeting
-
COOFANDY Marks 10th Anniversary with Dual Silver Awards at Berlin and New York Product Design Competitions
-
VCI Global Revises Equity Agreement with 102% Premium Pricing, Enhancing Strategic Flexibility
-
Zymeworks Announces Presentations Highlighting Breadth of Oncology Portfolio at Upcoming Medical Conferences
-
Cal Redwood Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
-
Maryna Karpenko Wins Top Industry Honors for Shaping Global Communication
-
Lynch Carpenter Investigates Claims in Harbin Clinic Data Breach
-
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
-
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
-
First Capital, Inc. Announces Quarterly Dividend
-
“Finish Line Campaign” Erases More than $83,000 of debt for Howard Community College Graduates, Continuing Students
-
From Onboarding to Settlement in Minutes: TransFi Launches BizPay to Redefine Global Business Payments
-
China's First Laozi Digital Human Unveiled in Sanmenxia, Henan
-
Guggenheim Second Quarter 2025 High Yield and Bank Loan Outlook: Credit Crossroads: Finding Value in an Era of Uncertainty
-
China's First Laozi Digital Human Unveiled in Sanmenxia, Henan
-
Guggenheim Second Quarter 2025 High Yield and Bank Loan Outlook: Credit Crossroads: Finding Value in an Era of Uncertainty
-
ESET participates in operation to disrupt the infrastructure of Danabot infostealer
-
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
